Matches in Nanopublications for { ?s ?p "[The cyclin-dependent kinase (CDK) inhibitor p27, which blocks G(1) to S phase transitions and is an important regulator of CDK2, is often decreased in hormonally regulated diseases, including uterine leiomyomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- assertion description "[The cyclin-dependent kinase (CDK) inhibitor p27, which blocks G(1) to S phase transitions and is an important regulator of CDK2, is often decreased in hormonally regulated diseases, including uterine leiomyomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The cyclin-dependent kinase (CDK) inhibitor p27, which blocks G(1) to S phase transitions and is an important regulator of CDK2, is often decreased in hormonally regulated diseases, including uterine leiomyomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP300841.RAYxbfa_ODkKKrfqGWfiNW1HrSNzTZ7VgE8PMCjlpl3lA130_assertion description "[The cyclin-dependent kinase (CDK) inhibitor p27, which blocks G(1) to S phase transitions and is an important regulator of CDK2, is often decreased in hormonally regulated diseases, including uterine leiomyomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP300841.RAYxbfa_ODkKKrfqGWfiNW1HrSNzTZ7VgE8PMCjlpl3lA130_provenance.
- assertion description "[The cyclin-dependent kinase (CDK) inhibitor p27, which blocks G(1) to S phase transitions and is an important regulator of CDK2, is often decreased in hormonally regulated diseases, including uterine leiomyomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The cyclin-dependent kinase (CDK) inhibitor p27, which blocks G(1) to S phase transitions and is an important regulator of CDK2, is often decreased in hormonally regulated diseases, including uterine leiomyomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1001910.RAV1gXkmD91J8wdODXANM-dp478oPtK9MdVno3WdpkcAg130_assertion description "[The cyclin-dependent kinase (CDK) inhibitor p27, which blocks G(1) to S phase transitions and is an important regulator of CDK2, is often decreased in hormonally regulated diseases, including uterine leiomyomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1001910.RAV1gXkmD91J8wdODXANM-dp478oPtK9MdVno3WdpkcAg130_provenance.
- NP300729.RApj7i-nfArP765rRWQrzTD08HuzOOGi13066pB3SSJdk130_assertion description "[The cyclin-dependent kinase (CDK) inhibitor p27, which blocks G(1) to S phase transitions and is an important regulator of CDK2, is often decreased in hormonally regulated diseases, including uterine leiomyomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP300729.RApj7i-nfArP765rRWQrzTD08HuzOOGi13066pB3SSJdk130_provenance.
- NP611638.RAjyC80qJUvmdOfVgoZAP0xecfRGZuFHOpUPn4hCQNPwI130_assertion description "[The cyclin-dependent kinase (CDK) inhibitor p27, which blocks G(1) to S phase transitions and is an important regulator of CDK2, is often decreased in hormonally regulated diseases, including uterine leiomyomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP611638.RAjyC80qJUvmdOfVgoZAP0xecfRGZuFHOpUPn4hCQNPwI130_provenance.
- NP1001900.RAu2SBoyPl_8YmS7GiOIPvda7yaca8ucwCrBg1GHDonvs130_assertion description "[The cyclin-dependent kinase (CDK) inhibitor p27, which blocks G(1) to S phase transitions and is an important regulator of CDK2, is often decreased in hormonally regulated diseases, including uterine leiomyomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1001900.RAu2SBoyPl_8YmS7GiOIPvda7yaca8ucwCrBg1GHDonvs130_provenance.
- NP1001903.RAqW1EdCj0LiN1-vD9DYKhWEKFXG5IUkjVBogXtMJrTh0130_assertion description "[The cyclin-dependent kinase (CDK) inhibitor p27, which blocks G(1) to S phase transitions and is an important regulator of CDK2, is often decreased in hormonally regulated diseases, including uterine leiomyomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1001903.RAqW1EdCj0LiN1-vD9DYKhWEKFXG5IUkjVBogXtMJrTh0130_provenance.
- NP611886.RAMqqg_D2uEYjTxXp97tQICSOZ1cXp_JNaWcKa7XMN_M0130_assertion description "[The cyclin-dependent kinase (CDK) inhibitor p27, which blocks G(1) to S phase transitions and is an important regulator of CDK2, is often decreased in hormonally regulated diseases, including uterine leiomyomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP611886.RAMqqg_D2uEYjTxXp97tQICSOZ1cXp_JNaWcKa7XMN_M0130_provenance.
- NP1001905.RAJofqPnpAb95_CW1PgyUlC0kCTeXS8mhzb5PGIt8pz_w130_assertion description "[The cyclin-dependent kinase (CDK) inhibitor p27, which blocks G(1) to S phase transitions and is an important regulator of CDK2, is often decreased in hormonally regulated diseases, including uterine leiomyomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1001905.RAJofqPnpAb95_CW1PgyUlC0kCTeXS8mhzb5PGIt8pz_w130_provenance.